LCI Learning

Share on Facebook

Share on Twitter

Share on LinkedIn

Share on Email

Share More

The Supreme Court suggested that the Centre should consider having an expert member on the Intellectual Property Appellate Board (IPAB) that reviews decisions of the Indian patent office. The case went to the apex court after the Madras High Court had asked the government to hear an appeal from Swiss pharmaceutical major Novartis against the rejection of a patent for its cancer medicine Glivec, without the panel having an expert member.

"Loved reading this piece by M Mahalakshmi?
Join LAWyersClubIndia's network for daily News Updates, Judgment Summaries, Articles, Forum Threads, Online Law Courses, and MUCH MORE!!"




  Views  419  Report



Comments
img